Abstract
We aimed to describe the outcomes, focusing on the hearing and neurological development, of infants born to mothers with COVID-19 during pregnancy and to evaluate the persistence of maternal antibodies in the first months of life. An observational, prospective study at a tertiary hospital in Madrid (Spain) on infants born to mothers with COVID-19 during pregnancy between March and September 2020 was conducted. A follow-up visit at 1–3 months of age with a physical and neurological examination, cranial ultrasound (cUS), SARS-CoV-2 RT-PCR on nasopharyngeal swab, and SARS-CoV-2 serology were performed. Hearing was evaluated at birth through the automated auditory brainstem response and at six months of age through the auditory steady-state response. A neurodevelopmental examination using the Bayley-III scale was performed at 12 months of age. Of 95 infants studied, neurological examination was normal in all of them at the follow-up visit, as was the cUS in 81/85 (95%) infants, with only mild abnormalities in four of them. Serology was positive in 47/95 (50%) infants, which was not associated with symptoms or severity of maternal infection. No hearing loss was detected, and neurodevelopment was normal in 96% of the infants (median Z score: 0).
Conclusion: In this cohort, the majority of infants born to mothers with COVID-19 during pregnancy were healthy infants with a normal cUS, no hearing loss, and normal neurodevelopment in the first year of life. Only half of the infants had a positive serological result during the follow-up.
What is Known: • Hearing loss and neurodevelopmental delay in infants born to mothers with COVID-19 during pregnancy has been suggested, although data is inconsistent. Maternal antibody transfer seems to be high, with a rapid decrease during the first weeks of life. | |
What is New: • Most infants born to mothers with COVID-19 during pregnancy had normal hearing screening, cranial ultrasound, and neurodevelopmental status at 12 months of life. Antibodies against SARS-CoV-2 were only detected in 50% of the infants at two months of life. |
Similar content being viewed by others
Availability of data and materials
After de-identification all the individual data collected for the study is available from the correspondent author under reasonable request.
Abbreviations
- COVID-19:
-
Coronavirus disease 2019
- cUS:
-
Cranial ultrasound
- IQR:
-
Interquartile range
- NICU:
-
Neonatal intensive care unit
- NPS:
-
Nasopharyngeal swab
- RT-PCR:
-
Reverse-transcription polymerase chain reaction
- SARS-CoV-2:
-
Severe acute respiratory syndrome coronavirus 2
- SD:
-
Standard deviation
- WGA:
-
Weeks of gestational age
References
Devakumar D, Bamford A, Ferreira MU et al (2018) Infectious causes of microcephaly: epidemiology, pathogenesis, diagnosis, and management. Lancet Infect Dis 18:e1–e13. https://doi.org/10.1016/S1473-3099(17)30398-5
Gazeta RE, Bertozzi APAP, Dezena RDCDAB et al (2021) Three-year clinical follow-up of children intrauterine exposed to zika virus. Viruses 13:1–15. https://doi.org/10.3390/v13030523
Lindan CE, Mankad K, Ram D et al (2021) Neuroimaging manifestations in children with SARS-CoV-2 infection: a multinational, multicentre collaborative study. Lancet Child Adolesc Heal 5:167–177. https://doi.org/10.1016/S2352-4642(20)30362-X
Walker KF, O’Donoghue K, Grace N et al (2020) Maternal transmission of SARS-COV-2 to the neonate, and possible routes for such transmission: a systematic review and critical analysis. BJOG An Int J Obstet Gynaecol 127:1324–1336. https://doi.org/10.1111/1471-0528.16362
Norman M, Navér L, Söderling J et al (2021) Association of maternal SARS-CoV-2 infection in pregnancy with neonatal outcomes. JAMA - J Am Med Assoc 325:2076–2086. https://doi.org/10.1001/jama.2021.5775
Angelidou A, Sullivan K, Melvin PR et al (2021) Association of maternal perinatal SARS-CoV-2 infection with neonatal outcomes during the COVID-19 pandemic in Massachusetts. JAMA Netw Open 4:1–14. https://doi.org/10.1001/jamanetworkopen.2021.7523
Vigil-Vázquez S, Carrasco-García I, Hernanz-Lobo A et al (2022) Impact of gestational COVID-19 on neonatal outcomes: is vertical infection possible? J Bone Jt Surg 41:466–472. https://doi.org/10.1097/INF.0000000000003518
Allotey J, Stallings E, Bonet M et al (2020) Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: Living systematic review and meta-analysis. BMJ. https://doi.org/10.1136/bmj.m3320
Hascoët JM, Jellimann JM, Hartard C et al (2020) Case series of COVID-19 asymptomatic newborns with possible intrapartum transmission of SARS-CoV-2. Front Pediatr 8:1–5. https://doi.org/10.3389/fped.2020.568979
Vivanti AJ, Vauloup-Fellous C, Prevot S et al (2020) Transplacental transmission of SARS-CoV-2 infection. Nat Commun 11:1–7. https://doi.org/10.1038/s41467-020-17436-6
Yu N, Li W, Kang Q et al (2020) Clinical features and obstetric and neonatal outcomes of pregnant patients with COVID-19 in Wuhan, China: a retrospective, single-centre, descriptive study. Lancet Infect Dis 20:559–564. https://doi.org/10.1016/S1473-3099(20)30176-6
Dumitriu D, Emeruwa UN, Hanft E et al (2021) Outcomes of neonates born to mothers with severe acute respiratory syndrome coronavirus 2 infection at a large medical center in New York City. JAMA Pediatr 175:157–167. https://doi.org/10.1001/jamapediatrics.2020.4298
Buonsenso D, Costa S, Giordano L et al (2022) Short- and mid-term multidisciplinary outcomes of newborns exposed to SARS-CoV-2 in utero or during the perinatal period: preliminary findings. Eur J Pediatr 181:1507–1520. https://doi.org/10.1007/s00431-021-04319-1
Shuffrey LC, Firestein MR, Kyle MH et al (2022) Association of birth during the COVID-19 pandemic with neurodevelopmental status at 6 months in infants with and without in utero exposure to maternal SARS-CoV-2 infection. JAMA Pediatr 10032:e215563. https://doi.org/10.1001/jamapediatrics.2021.5563
Alan MA, Alan C (2021) Hearing screening outcomes in neonates of SARS-CoV-2 positive pregnant women. Int J Pediatr Otorhinolaryngol 146:110754. https://doi.org/10.1016/j.ijporl.2021.110754
Celik T, Simsek A, Firat C et al (2020) Evaluation of cochlear functions in infants exposed to SARS-CoV-2 intrauterine. Am J Otolaryngol Neck Med Surg
Mulkey SB, Williams ME, Jadeed N et al (2022) Neurodevelopment in infants with antenatal or early neonatal exposure to SARS-CoV-2. Early Hum Dev 175:105694. https://doi.org/10.1016/j.earlhumdev.2022.105694
Aldrete-Cortez V, Bobadilla L, Tafoya SA et al (2022) Infants prenatally exposed to SARS-CoV-2 show the absence of fidgety movements and are at higher risk for neurological disorders: a comparative study. PLoS ONE 17:1–15. https://doi.org/10.1371/journal.pone.0267575
Edlow AG, Li JZ, Collier ARY et al (2020) Assessment of maternal and neonatal SARS-CoV-2 viral load, transplacental antibody transfer, and placental pathology in pregnancies during the COVID-19 pandemic. JAMA Netw open 3:e2030455. https://doi.org/10.1001/jamanetworkopen.2020.30455
Atyeo C, Pullen KM, Bordt EA et al (2021) Compromised SARS-CoV-2-specific placental antibody transfer. Cell 184:628-642.e10. https://doi.org/10.1016/j.cell.2020.12.027
Song D, Prahl M, Gaw SL et al (2021) Passive and active immunity in infants born to mothers with SARS-CoV-2 infection during pregnancy: prospective cohort study. BMJ Open. https://doi.org/10.1136/bmjopen-2021-053036
Joseph NT, Dude CM, Verkerke HP et al (2021) Maternal antibody response, neutralizing potency, and placental antibody transfer after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Obstet Gynecol 138:189–197. https://doi.org/10.1097/AOG.0000000000004440
Gao J, Li W, Hu X et al (2020) Disappearance of SARS-CoV-2 antibodies in infants born to women with COVID-19, Wuhan, China. Emerg Infect Dis 26:2491–2494. https://doi.org/10.3201/eid2610.202328
Martin-Vicente M, Carrasco I, Muñoz-Gomez MJ et al (2022) Antibody levels to SARS-CoV-2 spike protein in mothers and children from delivery to six months later. Birth. https://doi.org/10.1111/birt.12667
Villalaín C, Herraiz I, Luczkowiak J et al (2020) Seroprevalence analysis of SARS-CoV-2 in pregnant women along the first pandemic outbreak and perinatal outcome. PLoS ONE 15:1–12. https://doi.org/10.1371/journal.pone.0243029
Blumberg DA, Underwood MA, Hedriana HL, Lakshminrusimha S (2020) Vertical transmission of SARS-CoV-2: what is the optimal definition? Am J Perinatol 37:769–772. https://doi.org/10.1055/s-0040-1712457
Long QX, Tang XJ, Shi QL et al (2020) Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections. Nat Med 26:1200–1204. https://doi.org/10.1038/s41591-020-0965-6
Carrascosa A, Yeste D, Copil A et al (2004) Patrones antropométricos de los recién nacidos pretérmino y a término (24–42 semanas de edad gestacional) en el Hospital Materno-Infantil Vall d’Hebron (Barcelona) (1997–2002). An Pediatr 60:406–416. https://doi.org/10.1157/13059643
Lin YJ, Chiu NC, Chen HJ et al (2021) Cranial ultrasonographic screening findings among healthy neonates and their association with neurodevelopmental outcomes. Pediatr Neonatol 62:158–164. https://doi.org/10.1016/j.pedneo.2020.10.012
Villar J, Ariff S, Gunier RB et al (2021) Maternal and neonatal morbidity and mortality among pregnant women with and without COVID-19 infection: the INTERCOVID multinational cohort study. JAMA Pediatr 175:817–826. https://doi.org/10.1001/jamapediatrics.2021.1050
Conti MG, Terreri S, Piano Mortari E et al (2021) Immune response of neonates born to mothers infected with SARS-CoV-2. JAMA Netw Open 4:1–14. https://doi.org/10.1001/jamanetworkopen.2021.32563
Halasa NB, Olson SM, Staat MA et al (2022) Maternal Vaccination and risk of hospitalization for Covid-19 among infants. N Engl J Med. https://doi.org/10.1056/nejmoa2204399
Roberts DL, Rossman JS, Jarić I (2021) Dating first cases of COVID-19. PLoS Pathog 17:1–10. https://doi.org/10.1371/journal.ppat.1009620
Acknowledgements
The authors would like to thank Mark Sefton (BiomedRed SL) for his valuable assistance in the author editing of this manuscript.
Funding
This study was not specifically founded by any source. DBG (INT20/00086) and IHG (PI19/01005) hold “Intensification of Research Activity in the National Health System” contracts from the Instituto de Salud Carlos III, co-funded by the European Social Fund. SV was funded by the Spanish Ministry of Science and Innovation, Instituto de Salud Carlos III and Fondos FEDER (Contrato Río Hortega CM20/00173).
Author information
Authors and Affiliations
Contributions
Daniel Blázquez-Gamero conceived the study, designed the work, analyzed the data, interpretated the data, and drafted the manuscript. Jaime Carrasco Colom conceived the study, designed the work, contributed to the acquisition of the data, and revised and made valuable contributions to the manuscript. Ángela Manzanares conceived the study, contributed to the acquisition of the data, analyzed and interpretated the data, and drafted the manuscript. Estrella Esquivel analyzed and interpretated the data and made valuable contributions to the manuscript. Alfredo Pérez-Rivilla, Rafael Delgado, María Dolores Folgueira, Alberto Galindo, and María Teresa Moral-Pumarega designed the work and revised and made valuable intellectual contributions to the manuscript. Alicia Álvaro Gómez, Isabel Serrano Escribano, Elisa Aguirre Pascual, Joaquín de Vergas, Sara Reda del Barrio, Cinta Moraleda, Cristina Epalza, Elisa Fernández-Cooke, Luis Prieto, Berta Zamora, Serena Villaverde, and Ignacio Herraiz contributed to the acquisition of the data and revised and made valuable contributions to the final version of the manuscript. All authors approved the final manuscript as submitted and agree to be accountable for all aspects of the work.
Corresponding author
Ethics declarations
Ethics approval and consent to participate
The study was performed in line with the principles of the Declaration of Helsinki and was approved by the Ethics Committee of the Hospital Universitario 12 de Octubre (no. 20/241), and informed consent was obtained from the parents of all the infants that participated in the study.
Consent for publication
Not applicable.
Competing interests
The authors declare no competing interests.
Additional information
Communicated by Tobias Tenenbaum
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Carrasco Colom, J., Manzanares, Á., Álvaro Gómez, A. et al. Clinical outcomes and antibody transfer in a cohort of infants with in utero or perinatal exposure to SARS-CoV-2 (Coronascope Study). Eur J Pediatr 182, 4647–4654 (2023). https://doi.org/10.1007/s00431-023-05147-1
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00431-023-05147-1